Document is current
Any future updates will be listed below
-
Authors
Graafland, Charlotte H. https://orcid.org/0009-0000-2178-0032
Bunnik, Eline M. https://orcid.org/0000-0003-1481-6222
Borroni, Barbara https://orcid.org/0000-0001-9340-9814
Bouzigues, Arabella https://orcid.org/0000-0002-0267-8590
Borrego-Écija, Sergi https://orcid.org/0000-0003-2557-0010
Solje, Eino https://orcid.org/0000-0001-9940-9524
Graff, Caroline https://orcid.org/0000-0002-9949-2951
Rohrer, Jonathan D. https://orcid.org/0000-0002-6155-8417
van Swieten, John C. https://orcid.org/0000-0001-6278-6844
Donker Kaat, Laura https://orcid.org/0009-0007-2436-0931
Seelaar, Harro https://orcid.org/0000-0003-1989-7527
-
Funding
Funding for this research was provided by:
ZonMw (07330462210007)
ZonMw (07330462210007)
Association for Frontotemporal Degeneration (2024-005)
Association for Frontotemporal Degeneration (2024-005)
GIESKES-STRIJBIS FONDS
Alzheimer Nederland (WE.09-2022-05)
Alzheimer Nederland (WE.09-2022-05)
- License Information
-
More Information
Article History
Received: 24 September 2025
Accepted: 5 December 2025
First Online: 13 December 2025
Declarations
:
: Not applicable.
: Not applicable.
: E. Solje has served on the advisory board of Novartis, EISAI, Lilly and Roche, served as a consult for Novo Nordisk, BioaArctic, EISAI, Lilly and Roche and received honoraria from for lectures from Lundbeck, BioaArctic and Roche and travel support from Lilly. Other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
